ERBB2 and breast carcinoma: Nevertheless, data comparing [<sup>68</sup>Ga]Ga-FAPI-46 and [<sup>18</sup>F]FDG uptake in hormone receptor and/or HER2-positive breast cancer (luminal-like vs HER2-positive) remain scarce.